Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 27

Results For "Non"

1705 News Found

Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court
News | April 20, 2026

Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court

The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage


Cipla receives two observations following USFDA inspection at Goa facility
Drug Approval | April 18, 2026

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe


Department of Biotechnology invites applications for DBT Research Associateship 2025–26
Biotech | April 18, 2026

Department of Biotechnology invites applications for DBT Research Associateship 2025–26

Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences


Summer heat may strain liver health, say doctors on World Liver Day
Healthcare | April 18, 2026

Summer heat may strain liver health, say doctors on World Liver Day

Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures


Salve Group launches Parasoft foot cream to address dry and cracked feet
News | April 17, 2026

Salve Group launches Parasoft foot cream to address dry and cracked feet

This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture


Beyond beds and buildings: The quiet capital shift reshaping healthcare
Opinion | April 17, 2026

Beyond beds and buildings: The quiet capital shift reshaping healthcare

The investment case for health technology in India is frequently overstated in one direction and understated in another


Bayer flags major Phase III results for stroke prevention drug asundexian
Clinical Trials | April 17, 2026

Bayer flags major Phase III results for stroke prevention drug asundexian

The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy


DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia
Supply Chain | April 17, 2026

DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia

The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease


INST scientists develop glowing nanosensor for rapid nicotine, cotinine detection
R&D | April 16, 2026

INST scientists develop glowing nanosensor for rapid nicotine, cotinine detection

he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers


India chairs first BRICS Health Working Group meet
Policy | April 16, 2026

India chairs first BRICS Health Working Group meet

Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation